Themis Bioscience's Series A Round

Themis Bioscience raised a round of funding on May 23, 2011.

Themis Bioscience develops prophylactic vaccines with a focus on emerging tropical infectious diseases and has initial vaccine candidates currently in development for chikungunya and dengue fever. The…

Articles about Themis Bioscience's Series A Round: